2024-03-29T11:47:04Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00017415
2022-12-15T03:48:45Z
453:456
471:537:538:545
Thermo-Radio-Chemotherapy for Advanced Head and Neck Cancer : Report of 21 Cases with 27 Lesions during 10 Years (Hyperthermia for Cancer : Present Status in Various Clinical Fields)
2)頭頸部癌に対する温熱・放射線・化学療法 : 10年間 21症例 27病巣(シンポジウム 癌の温熱療法 : 各科領域における現状, 第519回新潟医学会シンポジウム)
2)頭頸部癌に対する温熱・放射線・化学療法 : 10年間 21症例 27病巣(シンポジウム 癌の温熱療法 : 各科領域における現状, 第519回新潟医学会シンポジウム)
星名, 秀行
109908
大橋, 靖
109909
鶴巻, 浩
109910
長島, 克弘
109911
hyperthermia
thermo-radio-chemotherapy
head and neck cancer
温熱療法
頭頸部癌
温熱・放射線・化学療法
Unresectable advanced or recurrent head and neck cancers have, since 1986, been treated by thermo-radio-chemotherapy(TRC)in our department. The results of TRC applied to 27 lesions in 21 patients are reported, and compared with the results of treatment with radiochemotherapy(RC)for 36 lesions in 30 patients. Twenty-seven lesions were treated with 3 heating systems(13 with a radiofrequency system, 12 with a microwave system and 2 with a radiofrequency interstitial system). Hyperthermia was performed for a total of 2 to 20 times(mean:9.4 times). A temperature exceeding 42℃ was attained in 209(82%)of 255 treatments. The mean total doses of irradiation were 54 Gy in the TRC group, and 57 Gy in the RC group. In the TRC group, 7(25.9%)of the 27 lesions treated showed a complete response(CR), 14(51.9%)a partial response(PR)and 6(22.2%)no change(NC), and the response rate(CR plus PR)was 77.8%. In the RC group, 6(16.7%)of the 36 lesions treated showed a CR, 16(44.4%)a PR and 14(38.9%)NC, and the response rate was 61.1%. The 5-year cumulative local control rate was 50.6% in the TRC group, and 20.4% in the RC group. In conclusion, TRC is an effective treatment for head and neck cancer.
departmental bulletin paper
新潟医学会
1997-05
application/pdf
新潟医学会雑誌
5
111
289
294
新潟医学会雑誌
AN00182415
00290440
https://niigata-u.repo.nii.ac.jp/record/17415/files/111(5)_289-294.pdf
jpn